Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

Transparency at the Food and Drug Administration.

Asamoah AK, Sharfstein JM.

N Engl J Med. 2010 Jun 24;362(25):2341-3. doi: 10.1056/NEJMp1005202. Epub 2010 May 19. No abstract available.

2.

Evaluating the safety of diabetes drugs: perspective of a Food and Drug Administration insider.

Misbin RI.

Diabetes Care. 2005 Oct;28(10):2573-6. Review. No abstract available.

PMID:
16186303
3.

U.S. Food and Drug Administration: Review for the Emergency Physician of Approval Process and Limitations.

Zuabi N, Patel B, Langdorf MI.

West J Emerg Med. 2016 Nov;17(6):741-746. Epub 2016 Sep 12. Review. No abstract available.

Supplemental Content

Support Center